Face filling agent composition for injection type cosmetic plastic surgery and preparation method of face filling agent composition
A filler and injection-type technology, which is applied in the field of facial filler composition for cosmetic plastic surgery and its preparation, can solve the problems of no skin repair effect, poor cross-linking effect of hyaluronic acid, redness and swelling in users, etc., and achieve inhibition of platelets Aggregation reaction, excellent biocompatibility, effect of promoting DNA synthesis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0026] Specific embodiment 1: This embodiment is an injectable facial filler composition for cosmetic plastic surgery, including cross-linked hyaluronic acid composite gel, hydroxyapatite particles, collagen powder, cellulose ethers, epimedium extract, Paeoniae Alba extract and aqueous solution for injection.
[0027] Principles and advantages of this embodiment:
[0028] 1. Tannic acid is a completely biodegradable material containing a glucose core of carbohydrates. The sources of tannic acid are all over the nature, mainly from bark, gallnut and other plants. Tannic acid is completely biodegradable and has a wide range of sources. The advantage of low cost; tannic acid can be used as a hemostatic agent on the surface of wounds and burns, and at the same time, tannic acid has a certain anti-infection effect, which can inhibit the production of some bacteria, thereby protecting the wound;
[0029] 2. Tannic acid has a unique branched structure and a large number of terminal ...
specific Embodiment approach 2
[0034] Specific embodiment two: the difference between this embodiment and specific embodiment one is: the cellulose ethers are methyl cellulose, sodium carboxymethyl cellulose, ethyl cellulose, carboxyethyl cellulose, hydroxypropyl cellulose One or a mixture of base cellulose and hydroxypropyl methyl cellulose. Other steps are the same as in the first embodiment.
specific Embodiment approach 3
[0035] Embodiment 3: The difference between this embodiment and Embodiment 1 or Embodiment 2 is that the particle size of the hydroxyapatite particles is 30 μm-40 μm. Other steps are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
quality score | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com